From: NY-ESO-1-specific T cell receptor-engineered T cells and Tranilast, a TRPV2 antagonist bivalent treatment enhances the killing of esophageal cancer: a dual-targeted cancer therapeutic route
Housekeeping gene
Oligo 1 (5ʹ to 3ʹ)
Oligo 2 (5ʹ to 3ʹ)
Product length (bp)
ACTB
GGCTGTGCTATCCCTGTACG
CTTGATCTTCATTGTGCTGGGTG
574
B2M
GCTCGCGCTACTCTCTCTTT
CACGGCAGGCATACTCATCT
278
GAPDH
GACCACAGTCCATGCCATCA
GTCAAAGGTGGAGGAGTGGG
364